Note: Fields marked with * are mandatory

Human Cell Line Activation Test

Topic : Skin sensitisation

Test Method Number: TM2008-05 (EU)
Short Name of TM: hCLAT
Year received: 2008
Responsible Organisation: EURL ECVAM - European Union '
Protocol(s)/SOP(s): 158
General Comments:

Test Guideline has been adopted as TG442E in July 2016

Method Description

The h-CLAT supports the discrimination between sensitizing and non-sensitizing chemicals

The h-CLAT quantifies in vitro changes in the expression of the CD86 and CD54 membrane phenotypic markers in a human monocytic leukemia cell line (THP-1 cells).

THP-1 cells are monocyte-derived cells that have shown to produce DC-like responses following exposure to skin sensitising chemicals (e.g. upregulation of surface markes (e.g. CD86 and CD54) and cytokine production (e.g. TNF-α).

The CD86 (a co-stimulatory molecule) and the CD54 (an adhesion molecule) are upregulated in activated Dendritic Cells (DC) and play a critical role in DC presentation of antigens to T cells (T-cell priming).

By studying the potential of test chemicals to up-regulate markers of DC activation, the h-CLAT generates information addressing key event 3 (dendritic cell activation) of the skin sensitization Adverse Outcome Pathway.

Track Approval Status

  • Submission
  • Validation
  • Peer-review
  • Recommendation
  • Regulatory acceptance/Standards
StepExpand All
 SubmissionShow status
 ValidationShow status
 Peer-reviewShow status
 RecommendationShow status
 Regulatory acceptance/StandardsShow status